Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Teishima

Showing results (161-170 of 240) with videos related to

Pageof 24
Sort By:
Clinical Genitourinary Cancer|July 17, 2024
Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling InhibitorsKotaro Suzuki, Yusuke Shiraishi, Junya Furukawa, et al.
International Journal of Clinical Oncology|June 27, 2026
Prevalence and complementary distribution of FGFR3 alterations and ERBB2 amplification in metastatic urothelial carcinoma: a nationwide registry analysisTakuto Hara, Taisuke Tobe, Hideto Ueki, et al.
Scientific Reports|July 10, 2021
Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironmentKeisuke Goto, Yukiko Honda, Kenichiro Ikeda, et al.
International Urology and Nephrology|March 26, 2025
Efficacy and safety of routine corticosteroid premedication in enfortumab vedotin therapy for advanced urothelial carcinomaTakuto Hara, Kotaro Suzuki, Taisuke Tobe, et al.
Japanese Journal of Radiology|February 3, 2016
A case of tubulocystic carcinoma of the kidney with aggressive featuresYoko Maeda, Keisuke Goto, Yukiko Honda, et al.
In Vivo (Athens, Greece)|January 1, 2022
Histopathological Analysis of False-positive Lesions in mpMRI/TRUS Fusion Prostate BiopsyRyoken Yamanaka, Yohei Sekino, Takashi Babasaki, et al.
Asian Journal of Urology|March 21, 2023
Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot studyYuki Kohada, Hiroki Kusumoto, Takashi Kukimoto, et al.
International Journal of Clinical Oncology|July 14, 2025
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patientsTaisuke Tobe, Jun Teishima, Hideto Ueki, et al.
Cancers|March 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial CarcinomaTakuto Hara, Naoto Wakita, Taisuke Tobe, et al.
Frontiers in Pediatrics|December 13, 2021
Case Report: Emphysematous Pyelonephritis With a Congenital Giant UreteroceleHiroyuki Kitano, Keisuke Hieda, Hiroki Kitagawa, et al.
Pageof 24

Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
Clinical Genitourinary Cancer|July 17, 2024
Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling InhibitorsKotaro Suzuki, Yusuke Shiraishi, Junya Furukawa, et al.
International Journal of Clinical Oncology|June 27, 2026
Prevalence and complementary distribution of FGFR3 alterations and ERBB2 amplification in metastatic urothelial carcinoma: a nationwide registry analysisTakuto Hara, Taisuke Tobe, Hideto Ueki, et al.
Scientific Reports|July 10, 2021
Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironmentKeisuke Goto, Yukiko Honda, Kenichiro Ikeda, et al.
International Urology and Nephrology|March 26, 2025
Efficacy and safety of routine corticosteroid premedication in enfortumab vedotin therapy for advanced urothelial carcinomaTakuto Hara, Kotaro Suzuki, Taisuke Tobe, et al.
Japanese Journal of Radiology|February 3, 2016
A case of tubulocystic carcinoma of the kidney with aggressive featuresYoko Maeda, Keisuke Goto, Yukiko Honda, et al.
In Vivo (Athens, Greece)|January 1, 2022
Histopathological Analysis of False-positive Lesions in mpMRI/TRUS Fusion Prostate BiopsyRyoken Yamanaka, Yohei Sekino, Takashi Babasaki, et al.
Asian Journal of Urology|March 21, 2023
Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot studyYuki Kohada, Hiroki Kusumoto, Takashi Kukimoto, et al.
International Journal of Clinical Oncology|July 14, 2025
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patientsTaisuke Tobe, Jun Teishima, Hideto Ueki, et al.
Cancers|March 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial CarcinomaTakuto Hara, Naoto Wakita, Taisuke Tobe, et al.
Frontiers in Pediatrics|December 13, 2021
Case Report: Emphysematous Pyelonephritis With a Congenital Giant UreteroceleHiroyuki Kitano, Keisuke Hieda, Hiroki Kitagawa, et al.
Pageof 24